Recent Advances in Food, Nutrition & Agriculture

Recent Advances in Food, Nutrition & Agriculture

Editor-in-Chief

ISSN (Print): 2772-574X
ISSN (Online): 2772-5758

Back Subscribe
Review Article

Recent Trends on Plants and Agricultural Products as Nutritional Source in Treating Diabetes

Author(s): Suryakant Verma* and Milind Sharad Pande

Volume 17, Issue 1, 2026

Published on: 23 December, 2024

Page: [1 - 20] Pages: 20

DOI: 10.2174/012772574X351036241122040415

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

A metabolic disease that requires insulin and is marked by consistently high blood sugar levels is known as diabetes mellitus. Many healthcare systems throughout the world have long relied on medicinal herbs as a means of addressing diabetes and its complications. Traditional medicine derived from plant extracts has several advantages over contemporary pharmaceuticals, including lower costs, greater clinical efficacy, and fewer side effects. Primarily, the condition has been managed by a range of synthetic medications that improve the altered glycemic state in individuals with diabetes. Synthetic medications work well, but along with their benefits, they come with noticeable adverse effects. Due to the lack of knowledge regarding their chemical composition, preparation method, active bio-actives, potential side effects, and the optimal way to administer them, medicinal plants have not been fully utilised as acceptable drugs in the treatment of diabetes, despite their long history of use as primary health care. Because of a lack of sufficient data on the parameters described earlier, most medicinal plants that show promise as anti-diabetic agents do not make it to the clinical trial phase. Medicinal plants that have been studied in humans with diabetes and shown promise as a treatment for the disease, either alone or in conjunction with other plants, are summarised in this review. Pharmacologically active phytomolecules with an antidiabetic action that are derived from medicinal plants were the primary topic of this review article. Its goal was to discuss their importance in diabetes management and therapy. These all-natural substances have the potential to be successful and alternative diabetes treatments, as well as a new method of approaching the disease.

Keywords: Diabetes prevention, herbal remedies, action mechanisms, human clinical trial, traditional medicine, phytomolecules.

Next »

Graphical Abstract

[1]
Goyal R, Singhal M, Jialal I. Type 2 diabetes. StatPearls. Treasure Island, FL: StatPearls Publishing 2024.
[PMID: 30020625]
[2]
Dilworth L, Facey A, Omoruyi F. Diabetes mellitus and its metabolic complications: The role of adipose tissues. Int J Mol Sci 2021; 22(14): 7644.
[http://dx.doi.org/10.3390/ijms22147644] [PMID: 34299261]
[3]
International Diabetes Federation. IDF Diabetes Atlas. 9th ed Brussels: International Diabetes Federation 2019. Available from: https://www.spd.pt/images/idf_atlas_9th_edition_2019.pdf
[4]
Medagama AB, Bandara R. The use of complementary and alternative medicines (CAMs) in the treatment of diabetes mellitus: Is continued use safe and effective? Nutr J 2014; 13(1): 102.
[http://dx.doi.org/10.1186/1475-2891-13-102] [PMID: 25331834]
[5]
Alqathama A, Alluhiabi G, Baghdadi H, et al. Herbal medicine from the perspective of type II diabetic patients and physicians: What is the relationship? BMC Complement Med Ther 2020; 20(1): 65.
[http://dx.doi.org/10.1186/s12906-020-2854-4] [PMID: 32111222]
[6]
Kesavadev J, Saboo B, Sadikot S, et al. Unproven therapies for diabetes and their implications. Adv Ther 2017; 34(1): 60-77.
[http://dx.doi.org/10.1007/s12325-016-0439-x] [PMID: 27864668]
[7]
World Health Organization. Global report on diabetes 2016. Geneva: WHO 2016. Available from: https://www.who.int/publications/i/item/9789241565257
[8]
Naveen YP, Urooj A, Byrappa K. A review on medicinal plants evaluated for anti-diabetic potential in clinical trials: Present status and future perspective. J Herb Med 2021; 28: 100436.
[http://dx.doi.org/10.1016/j.hermed.2021.100436]
[9]
Nanda M, Sharma R. Financial burden of seeking diabetes mellitus care in India: Evidence from a Nationally Representative Sample Survey. Health Care Science 2023; 2(5): 291-305.
[http://dx.doi.org/10.1002/hcs2.65] [PMID: 38938589]
[10]
Gordon A, Buch Z, Baute V, Coeytaux R. Use of ayurveda in the treatment of type 2 diabetes mellitus. Glob Adv Health Med 2019; 8: 2164956119861094.
[http://dx.doi.org/10.1177/2164956119861094] [PMID: 31431828]
[11]
Dirir AM, Daou M, Yousef AF, Yousef LF. A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetes. Phytochem Rev 2022; 21(4): 1049-79.
[http://dx.doi.org/10.1007/s11101-021-09773-1] [PMID: 34421444]
[12]
Salleh NH, Zulkipli IN, Mohd Yasin H, et al. Systematic review of medicinal plants used for treatment of diabetes in human clinical trials: An ASEAN perspective. Evid Based Complement Alternat Med 2021; 2021(1): 1-10.
[http://dx.doi.org/10.1155/2021/5570939] [PMID: 34691218]
[13]
Aggarwal N. Shishu. A review of recent investigations on medicinal herbs possessing anti-diabetic properties. J Nutr Disord Ther 2011; 1(102): 2.
[http://dx.doi.org/10.4172/2161-0509.1000102]
[14]
Kayarohanam S, Kavimani S. Current trends of plants having antidiabetic activity: A review. J Bioanal Biomed 2015; 7(2): 55-65.
[http://dx.doi.org/10.4172/1948-593X.1000124]
[15]
Sidhu MC, Sharma T. Medicinal plants from twelve families having antidiabetic activity: A review. Am J PharmTech Res 2013; 3: 36-52.
[16]
World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO consultation Part 1, Diagnosis and classification of diabetes mellitus World Health Organization 1999. Available from: https://iris.who.int/handle/10665/66040
[17]
American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes - 2019. Diabetes Care 2019; 42 (Suppl. 1): S13-28.
[http://dx.doi.org/10.2337/dc19-S002] [PMID: 30559228]
[18]
Heise T, Nosek L, Rønn BB, et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes 2004; 53(6): 1614-20.
[http://dx.doi.org/10.2337/diabetes.53.6.1614] [PMID: 15161770]
[19]
McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers 2019; 5(1): 47.
[http://dx.doi.org/10.1038/s41572-019-0098-8] [PMID: 31296866]
[20]
Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K. Microvascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol 2020; 18(2): 117-24.
[http://dx.doi.org/10.2174/1570161117666190502103733] [PMID: 31057114]
[21]
Mayfield J. Diagnosis and classification of diabetes mellitus: New criteria. Am Fam Physician 1998; 58(6): 1355-1362, 1369-1370.
[PMID: 9803200]
[22]
Knight K, Badamgarav E, Henning JM, et al. A systematic review of diabetes disease management programs. Am J Manag Care 2005; 11(4): 242-50.
[PMID: 15839184]
[23]
Colberg SR, Sigal RJ, Yardley JE, et al. Physical activity/exercise and diabetes: A position statement of the American Diabetes Association. Diabetes Care 2016; 39(11): 2065-79.
[http://dx.doi.org/10.2337/dc16-1728] [PMID: 27926890]
[24]
Khan MU. Lifestyle modification in the prevention of type II diabetes mellitus. Oman Med J 2012; 27(2): 170-1.
[http://dx.doi.org/10.5001/omj.2012.36] [PMID: 22496947]
[25]
DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999; 131(4): 281-303.
[http://dx.doi.org/10.7326/0003-4819-131-4-199908170-00008] [PMID: 10454950]
[26]
Goldberg RB, Kendall DM, Deeg MA, et al. A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia. Diabetes Care 2005; 28(7): 1547-54.
[http://dx.doi.org/10.2337/diacare.28.7.1547] [PMID: 15983299]
[27]
Home PD, Pocock SJ, Beck-Nielsen H, et al. Rosiglitazone evaluated for cardiovascular outcomes - An interim analysis. N Engl J Med 2007; 357(1): 28-38.
[http://dx.doi.org/10.1056/NEJMoa073394] [PMID: 17551159]
[28]
Singh S, Loke YK, Furberg CD. Thiazolidinediones and heart failure: A teleo-analysis. Diabetes Care 2007; 30(8): 2148-53.
[http://dx.doi.org/10.2337/dc07-0141] [PMID: 17536074]
[29]
Siconolfi-Baez L, Banerji MA, Lebovitz HE. Characterization and significance of sulfonylurea receptors. Diabetes Care 1990; 13 (Suppl. 3): 2-8.
[http://dx.doi.org/10.2337/diacare.13.3.2] [PMID: 2209340]
[30]
Simonson DC, Ferrannini E, Bevilacqua S, et al. Mechanism of improvement in glucose metabolism after chronic glyburide therapy. Diabetes 1984; 33(9): 838-45.
[http://dx.doi.org/10.2337/diab.33.9.838] [PMID: 6432610]
[31]
Sahu B. Comprehensive review on non-alcoholic fatty liver disease (NAFLD): Clinical advancement and drug treatments. Prob Sci 2024; 1(1): 1-7.
[32]
Mishra A. Impact of sewage water on behavioral response and oxygen consumption of fish Clarius batrachus. Prob Sci 2024; 1(1): 8-14.
[33]
Sinha L, Jain SK, Choudhary R. Current trends in the treatment of hepatocellular carcinoma: Clinical applications and advancement. Prob Sci 2024; 1(1): 24-33.
[34]
Kumar MK, Narayan S, Singh PK. A review on advancement of mouth dissolving tablets. Prob Sci 2024; 1(1): 34-49.
[35]
Khan MF, Rawat AK, Khatoon S, Hussain MK, Mishra A, Negi DS. In vitro and in vivo antidiabetic effect of extracts of Melia azedarach, Zanthoxylum alatum, and Tanacetum nubigenum. Integr Med Res 2018; 7(2): 176-83.
[http://dx.doi.org/10.1016/j.imr.2018.03.004] [PMID: 29984178]
[36]
Wang W, Xu J, Fang H, Li Z, Li M. Advances and challenges in medicinal plant breeding. Plant Sci 2020; 298: 110573.
[http://dx.doi.org/10.1016/j.plantsci.2020.110573] [PMID: 32771174]
[37]
Wu JY, Wang TY, Ding HY, Zhang YR, Lin SY, Chang TS. Enzymatic synthesis of novel vitexin glucosides. Molecules 2021; 26(20): 6274.
[http://dx.doi.org/10.3390/molecules26206274] [PMID: 34684855]
[38]
Dwitiyanti DD, Harahap Y, Elya B, Bahtiar A. Study of molecular docking of vitexin in binahong (Anredera cordifolia (Ten.) Steenis) leaves extract on glibenclamide-CYP3A4 interaction. Pharmacogn J 2019; 11(6s): 1471-6.
[http://dx.doi.org/10.5530/pj.2019.11.227]
[39]
Tran N, Pham B, Le L. Bioactive compounds in anti-diabetic plants: From herbal medicine to modern drug discovery. Biology (Basel) 2020; 9(9): 252.
[http://dx.doi.org/10.3390/biology9090252] [PMID: 32872226]
[40]
Meliani N, Dib MEA, Allali H, Tabti B. Hypoglycaemic effect of Berberis vulgaris L. in normal and streptozotocin-induced diabetic rats. Asian Pac J Trop Biomed 2011; 1(6): 468-71.
[http://dx.doi.org/10.1016/S2221-1691(11)60102-0] [PMID: 23569815]
[41]
El Barky A, Hussein S, Alm-Eldeen A, Hafez A, Mohamed T. Saponins and their potential role in diabetes mellitus. Diabetes Manag 2017; 7: 148-58.
[42]
Philpott DJ, Butzner JD, Meddings JB. Regulation of intestinal glucose transport. Can J Physiol Pharmacol 1992; 70(9): 1201-7.
[http://dx.doi.org/10.1139/y92-167] [PMID: 1493588]
[43]
Kumari M, Jain S. Tannins: An antinutrient with positive effect to manage diabetes. Res J Recent Sci 2012; 1(12): 70-3.
[44]
Kim MJ, Ryu GR, Chung JS, et al. Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: In vivo and in vitro. Pancreas 2003; 26(3): 292-9.
[http://dx.doi.org/10.1097/00006676-200304000-00014] [PMID: 12657957]
[45]
Kumar D, Ghosh R, Pal BC. α-glucosidase inhibitory terpenoids from Potentilla fulgens and their quantitative estimation by validated HPLC method. J Funct Foods 2013; 5(3): 1135-41.
[http://dx.doi.org/10.1016/j.jff.2013.03.010]
[46]
Mbaze LM, Poumale HMP, Wansi JD, et al. α-Glucosidase inhibitory pentacyclic triterpenes from the stem bark of Fagara tessmannii (Rutaceae). Phytochemistry 2007; 68(5): 591-5.
[http://dx.doi.org/10.1016/j.phytochem.2006.12.015] [PMID: 17270224]
[47]
Eliza J, Daisy P, Ignacimuthu S, Duraipandiyan V. Normo-glycemic and hypolipidemic effect of costunolide isolated from Costus speciosus (Koen ex. Retz.)Sm. in streptozotocin-induced diabetic rats. Chem Biol Interact 2009; 179(2-3): 329-34.
[http://dx.doi.org/10.1016/j.cbi.2008.10.017] [PMID: 19007766]
[48]
Prasad S, Kalra N, Shukla Y. Hepatoprotective effects of lupeol and mango pulp extract of carcinogen induced alteration in Swiss albino mice. Mol Nutr Food Res 2007; 51(3): 352-9.
[http://dx.doi.org/10.1002/mnfr.200600113] [PMID: 17340578]
[49]
Zaharudin N, Staerk D, Dragsted LO. Inhibition of α-glucosidase activity by selected edible seaweeds and fucoxanthin. Food Chem 2019; 270: 481-6.
[http://dx.doi.org/10.1016/j.foodchem.2018.07.142] [PMID: 30174076]
[50]
Sok Yen F, Shu Qin C, Tan Shi Xuan S, et al. Hypoglycemic efects of plant flavonoids: A review. Evid Based Complement Alternat Med 2021; 2021: 1-12.
[http://dx.doi.org/10.1155/2021/2057333] [PMID: 34925525]
[51]
Kapoor R, Kakkar P. Protective role of morin, a flavonoid, against high glucose induced oxidative stress mediated apoptosis in primary rat hepatocytes. PLoS One 2012; 7(8): e41663.
[http://dx.doi.org/10.1371/journal.pone.0041663] [PMID: 22899998]
[52]
Yongchaiyudha S, Rungpitarangsi V, Bunyapraphatsara N, Chokechaijaroenporn O. Antidiabetic activity of Aloe vera L. juice. I. Clinical trial in new cases of diabetes mellitus. Phytomedicine 1996; 3(3): 241-3.
[http://dx.doi.org/10.1016/S0944-7113(96)80060-2] [PMID: 23195077]
[53]
Agarwal R, Sulaiman SA, Mohamed M. Open label clinical trial to study adverse effects and tolerance to dry powder of the aerial part of Andrographis paniculata in patients type 2 with diabetes mellitus. Malays J Med Sci 2005; 12(1): 13-9.
[PMID: 22605942]
[54]
Lou JS, Dimitrova DM, Murchison C, et al. Centella asiatica triterpenes for diabetic neuropathy: A randomized, double-blind, placebo-controlled, pilot clinical study. Esperienze Dermatol 2018; 20(2) (Suppl. 1): 12-22.
[http://dx.doi.org/10.23736/S1128-9155.18.00455-7] [PMID: 31080345]
[55]
Chusak C, Thilavech T, Henry CJ, Adisakwattana S. Acute effect of Clitoria ternatea flower beverage on glycemic response and antioxidant capacity in healthy subjects: A randomized crossover trial. BMC Complement Altern Med 2018; 18(1): 6.
[http://dx.doi.org/10.1186/s12906-017-2075-7] [PMID: 29310631]
[56]
Cheng SH, Ismail A, Anthony J, Ng OC, Hamid AA, Barakatun-Nisak MY. Eight weeks of Cosmos caudatus (Ulam Raja) supplementation improves glycemic status in patients with type 2 diabetes: A randomized controlled trial. Evid Based Complement Alternat Med 2015; 2015: 1-7.
[http://dx.doi.org/10.1155/2015/405615] [PMID: 26713097]
[57]
Gutiérrez RMP, Mitchell S, Solis RV. Psidium guajava: A review of its traditional uses, phytochemistry and pharmacology. J Ethnopharmacol 2008; 117(1): 1-27.
[http://dx.doi.org/10.1016/j.jep.2008.01.025] [PMID: 18353572]
[58]
Neelakantan N, Narayanan M, de Souza RJ, van Dam RM. Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: A meta-analysis of clinical trials. Nutr J 2014; 13(1): 7.
[http://dx.doi.org/10.1186/1475-2891-13-7] [PMID: 24438170]
[59]
Li WL, Zheng HC, Bukuru J, De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol 2004; 92(1): 1-21.
[http://dx.doi.org/10.1016/j.jep.2003.12.031] [PMID: 15099842]
[60]
Rathi SS, Grover JK, Vats V. The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism. Phytother Res 2002; 16(3): 236-43.
[http://dx.doi.org/10.1002/ptr.842] [PMID: 12164268]
[61]
Saeed F, Afzaal M, Niaz B, et al. Bitter melon (Momordica charantia): A natural healthy vegetable. Int J Food Prop 2018; 21(1): 1270-90.
[http://dx.doi.org/10.1080/10942912.2018.1446023]
[62]
Dandawate PR, Subramaniam D, Padhye SB, Anant S. Bitter melon: A panacea for inflammation and cancer. Chin J Nat Med 2016; 14(2): 81-100.
[http://dx.doi.org/10.1016/S1875-5364(16)60002-X] [PMID: 26968675]
[63]
Ibrahim TA, El-Hefnawy HM, El-Hela AA. Antioxidant potential and phenolic acid content of certain cucurbitaceous plants cultivated in Egypt. Nat Prod Res 2010; 24(16): 1537-45.
[http://dx.doi.org/10.1080/14786419.2010.489049] [PMID: 20835955]
[64]
Tan S, Stathopoulos C, Parks S, Roach P. An optimised aqueous extract of phenolic compounds from bitter melon with high antioxidant capacity. Antioxidants 2014; 3(4): 814-29.
[http://dx.doi.org/10.3390/antiox3040814] [PMID: 26785242]
[65]
Popovich DG, Li L, Zhang W. Bitter melon (Momordica charantia) triterpenoid extract reduces preadipocyte viability, lipid accumulation and adiponectin expression in 3T3-L1 cells. Food Chem Toxicol 2010; 48(6): 1619-26.
[http://dx.doi.org/10.1016/j.fct.2010.03.035] [PMID: 20347917]
[66]
Chuang CY, Hsu C, Chao CY, Wein YS, Kuo YH, Huang C. Fractionation and identification of 9c, 11t, 13t-conjugated linolenic acid as an activator of PPARα in bitter gourd (Momordica charantia L.). J Biomed Sci 2006; 13(6): 763-72.
[http://dx.doi.org/10.1007/s11373-006-9109-3] [PMID: 16955349]
[67]
Ahmad Z, Zamhuri KF, Yaacob A, et al. In vitro anti-diabetic activities and chemical analysis of polypeptide-k and oil isolated from seeds of Momordica charantia (bitter gourd). Molecules 2012; 17(8): 9631-40.
[http://dx.doi.org/10.3390/molecules17089631] [PMID: 22885359]
[68]
Keller AC, Ma J, Kavalier A, He K, Brillantes AMB, Kennelly EJ. Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro. Phytomedicine 2011; 19(1): 32-7.
[http://dx.doi.org/10.1016/j.phymed.2011.06.019] [PMID: 22133295]
[69]
Sasa M, Inoue I, Shinoda Y, et al. Activating effect of momordin, extract of bitter melon (Momordica charantia L.), on the promoter of human PPARdelta. J Atheroscler Thromb 2009; 16(6): 888-92.
[http://dx.doi.org/10.5551/jat.2790] [PMID: 20032574]
[70]
Khanna P, Jain SC, Panagariya A, Dixit VP. Hypoglycemic activity of polypeptide-p from a plant source. J Nat Prod 1981; 44(6): 648-55.
[http://dx.doi.org/10.1021/np50018a002] [PMID: 7334382]
[71]
Dans AML, Villarruz MVC, Jimeno CA, et al. The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies. J Clin Epidemiol 2007; 60(6): 554-9.
[http://dx.doi.org/10.1016/j.jclinepi.2006.07.009] [PMID: 17493509]
[72]
Jiang B, Ji M, Liu W, et al. Antidiabetic activities of a cucurbitane-type triterpenoid compound from Momordica charantia in alloxan-induced diabetic mice. Mol Med Rep 2016; 14(5): 4865-72.
[http://dx.doi.org/10.3892/mmr.2016.5800] [PMID: 27748816]
[73]
Attele AS, Zhou YP, Xie JT, et al. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002; 51(6): 1851-8.
[http://dx.doi.org/10.2337/diabetes.51.6.1851] [PMID: 12031973]
[74]
Park JD, Rhee DK, Lee YH. Biological activities and chemistry of saponins from Panax ginseng C.A. meyer. Phytochem Rev 2005; 4(2-3): 159-75.
[http://dx.doi.org/10.1007/s11101-005-2835-8]
[75]
Ratan ZA, Haidere MF, Hong YH, et al. Pharmacological potential of ginseng and its major component ginsenosides. J Ginseng Res 2021; 45(2): 199-210.
[PMID: 33841000]
[76]
Chohachi K, Miki M, Yoshiteru O, Hiroshi H. Isolation and hypoglycemic activity of Panaxans Q, R, S, T and U, glycans of Panax ginseng roots. J Ethnopharmacol 1985; 14(1): 69-74.
[http://dx.doi.org/10.1016/0378-8741(85)90030-3] [PMID: 4087924]
[77]
Kimura M, Waki I, Tanaka O, Nagai Y, Shibata S. Pharmacological sequential trials for the fractionation of components with hypoglycemic activity in alloxan diabetic mice from ginseng radix. J Pharmacobiodyn 1981; 4(6): 402-9.
[http://dx.doi.org/10.1248/bpb1978.4.402] [PMID: 7288557]
[78]
Yokozawa T, Kobayashi T, Oura H, Kawashima Y. Studies on the mechanism of the hypoglycemic activity of ginsenoside-Rb2 in streptozotocin-diabetic rats. Chem Pharm Bull (Tokyo) 1985; 33(2): 869-72.
[http://dx.doi.org/10.1248/cpb.33.869] [PMID: 4017130]
[79]
Sharma P, Dubey G, Kaushik S. Chemical and Medico-biological profile of Cyamopsis tetragonoloba (L) Taub: An overview. J Appl Pharm Sci 2011; 1: 32-7.
[80]
Atta-Ur-Rahman , Zaman K. Medicinal plants with hypoglycemic activity. J Ethnopharmacol 1989; 26(1): 1-55.
[http://dx.doi.org/10.1016/0378-8741(89)90112-8] [PMID: 2664356]
[81]
Mukhtar HM, Ansari SH, Bhat ZA, Naved T. Antihyperglycemic activity of Cyamopsis tetragonoloba. beans on blood glucose levels in alloxan-induced diabetic rats. Pharm Biol 2006; 44(1): 10-3.
[http://dx.doi.org/10.1080/13880200500509025]
[82]
Gandhi GR, Vanlalhruaia P, Stalin A, Irudayaraj SS, Ignacimuthu S, Paulraj MG. Polyphenols-rich Cyamopsis tetragonoloba (L.) Taub. beans show hypoglycemic and β-cells protective effects in type 2 diabetic rats. Food Chem Toxicol 2014; 66: 358-65.
[http://dx.doi.org/10.1016/j.fct.2014.02.001] [PMID: 24525096]
[83]
Ajabnoor MA. Effect of aloes on blood glucose levels in normal and alloxan diabetic mice. J Ethnopharmacol 1990; 28(2): 215-20.
[http://dx.doi.org/10.1016/0378-8741(90)90031-N] [PMID: 2109811]
[84]
Patel DK, Patel K, Dhanabal SP. Phytochemical standardization of Aloe vera extract by HPTLC techniques. J Acute Dis 2012; 1(1): 47-50.
[http://dx.doi.org/10.1016/S2221-6189(13)60011-6]
[85]
Das SK, Vasudevan DM. Tulsi: The Indian holy power plant. Nat Prod Rad 2006; 5: 279-83.
[86]
Verma S. Chemical constituents and pharmacological action of Ocimum sanctum (Indian holy basil-Tulsi). J Phytopharmacol 2016; 5(5): 205-7.
[http://dx.doi.org/10.31254/phyto.2016.5507]
[87]
Rahman S, Islam R, Kamruzzaman M, Alam K, Jamal ARM. Ocimum sanctum L.: A review of phytochemical and pharmacological profile. Am J Drug Discov Develop 2011; 1: 1-5.
[http://dx.doi.org/10.3923/ajdd.2011]
[88]
Singh D, Chaudhuri PK. A review on phytochemical and pharmacological properties of Holy basil (Ocimum sanctum L.). Ind Crops Prod 2018; 118: 367-82.
[http://dx.doi.org/10.1016/j.indcrop.2018.03.048]
[89]
Hannan JMA, Marenah L, Ali L, Rokeya B, Flatt PR, Abdel-Wahab YHA. Ocimum sanctum leaf extracts stimulate insulin secretion from perfused pancreas, isolated islets and clonal pancreatic β-cells. J Endocrinol 2006; 189(1): 127-36.
[http://dx.doi.org/10.1677/joe.1.06615] [PMID: 16614387]
[90]
Hannan J, Ojo O, Rokeya L, et al. Actions underlying antidiabetic effects of Ocimum sanctum leaf extracts in animal models of type 1 and type 2 diabetes. European J Med Plants 2015; 5(1): 1-12.
[http://dx.doi.org/10.9734/EJMP/2015/11840]
[91]
World Health Organization WHO monographs on selected medicinal plants Geneva: WHO; 2006 Report No: WHO/EMP/MIE/20 061 Available from: https://www.who.int/publications/i/item/92 41545178
[92]
Kumari K, Mathew BC, Augusti KT. Antidiabetic and hypolipidemic effects of S-methyl cysteine sulfoxide isolated from Allium cepa Linn. Indian J Biochem Biophys 1995; 32(1): 49-54.
[PMID: 7665195]
[93]
Lakshmi MS, Rani KSS, Reddy UTK. A review on diabetes mellitus and the herbal plants used for its treatment. Asian J Pharm Clin Res 2012; 5: 15-21.
[94]
Galal EE, Gawad MA. Antidiabetic activity of Egyptian onion “Allium cepa” extract. J Egypt Med Assoc 1965; 48: 14-45.
[PMID: 5873670]
[95]
Kumari K, Augusti KT. Antidiabetic and antioxidant effects of S-methyl cysteine sulfoxide isolated from onions (Allium cepa Linn) as compared to standard drugs in alloxan diabetic rats. Indian J Exp Biol 2002; 40(9): 1005-9.
[PMID: 12587728]
[96]
Das S. Garlic - A natural source of cancer preventive compounds. Asian Pac J Cancer Prev 2002; 3(4): 305-11.
[PMID: 12716288]
[97]
Devi R. GM A. A comprehensive review on Costus pictus D. Don. Int J Pharm Sci Res 2019; 10: 3187-95.
[98]
Rao HA, Rao P, Hegde PK, Rao PN. A review on insulin plant (Costus igneus Nak). Pharmacogn Rev 2014; 8(15): 67-72.
[http://dx.doi.org/10.4103/0973-7847.125536] [PMID: 24600198]
[99]
Jothivel N, Ponnusamy SP, Appachi M, et al. Anti-diabetic activity of methanol leaf extract of Costus pictus D. Don in alloxan-induced diabetic rats. J Health Sci 2007; 53(6): 655-63.
[http://dx.doi.org/10.1248/jhs.53.655]
[100]
Peasari J, Motamarry S, Varma KS, Anitha P, Potti RB. Chromatographic analysis of phytochemicals in Costus igneus and computational studies of flavonoids. Informat Med Unlocked 2018; 13: 34-40.
[http://dx.doi.org/10.1016/j.imu.2018.10.004]
[101]
Sidhu AK, Wani S, Tamboli PS, Patil SN. In vitro evaluation of anti-diabetic activity of leaf and callus extracts of Costus pictus. Int J Recent Sci Res 2014; 3: 1622-5.
[102]
Kwon YI, Apostolidis E, Kim YC, Shetty K. Health benefits of traditional corn, beans, and pumpkin: In vitro studies for hyperglycemia and hypertension management. J Med Food 2007; 10(2): 266-75.
[http://dx.doi.org/10.1089/jmf.2006.234] [PMID: 17651062]
[103]
Kazeem MI, Ashafa AOT. In vitro antioxidant and antidiabetic potentials of Dianthus basuticus Burtt Davy whole plant extracts. J Herb Med 2015; 5(3): 158-64.
[http://dx.doi.org/10.1016/j.hermed.2015.06.003]
[104]
Bhutkar M, Bhise SB. In vitro assay of alpha amylase inhibitory activity of some indigenous plants. Int J Chem Sci 2012; 10: 457-62.
[105]
Mahmood N. A review of α-amylase inhibitors on weight loss and glycemic control in pathological state such as obesity and diabetes. Comp Clin Pathol 2016; 25(6): 1253-64.
[http://dx.doi.org/10.1007/s00580-014-1967-x]
[106]
Souza PM, Magalhães PO. Application of microbial α-amylase in industry - A review. Braz J Microbiol 2010; 41(4): 850-61.
[http://dx.doi.org/10.1590/S1517-83822010000400004] [PMID: 24031565]
[107]
Jayasri MA, Gunasekaran S, Radha A, Mathew TL. Anti-diabetic effect of Costus pictus leaves in normal and streptozotocin-induced diabetic rats. Int J Diabetes Metab 2008; 16(3): 117-22.
[http://dx.doi.org/10.1159/000497662]
[108]
Radha JMA, Mathew TL. α-amylase and α-glucosidase inhibitory activity of Costus pictus D. Don in the management of diabetes. J Herb Med Toxicol 2009; 3: 91-4.https://www.scirp.org/reference/referencespapers?referenceid=711597
[109]
Ferosekhan M, Ramu A, Ravikumar S. Scientific evaluation of traditionally known insulin plant Costus species for the treatment of diabetes in human. Int J Curr Res Biosci Plant Biol 2016; 3(6): 87-91.
[http://dx.doi.org/10.20546/ijcrbp.2016.306.011]
[110]
Gireesh G, Thomas SK, Joseph B, Paulose CS. Antihyperglycemic and insulin secretory activity of Costus pictus leaf extract in streptozotocin induced diabetic rats and in in vitro pancreatic islet culture. J Ethnopharmacol 2009; 123(3): 470-4.
[http://dx.doi.org/10.1016/j.jep.2009.03.026] [PMID: 19501280]
[111]
Al-Romaiyan A, Jayasri MA, Mathew TL, et al. Costus pictus extracts stimulate insulin secretion from mouse and human islets of langerhans in vitro. Cell Physiol Biochem 2010; 26(6): 1051-8.
[http://dx.doi.org/10.1159/000324007] [PMID: 21220936]
[112]
Dhanabal SP, Kokate CK, Ramanathan M, Kumar EP, Suresh B. Hypoglycaemic activity of Pterocarpus marsupium Roxb. Phytother Res 2006; 20(1): 4-8.
[http://dx.doi.org/10.1002/ptr.1819] [PMID: 16397913]
[113]
Manickam M, Ramanathan M, Farboodniay Jahromi MA, Chansouria JPN, Ray AB. Antihyperglycemic activity of phenolics from Pterocarpus marsupium. J Nat Prod 1997; 60(6): 609-10.
[http://dx.doi.org/10.1021/np9607013] [PMID: 9214733]
[114]
Moqbel FS, Naik PR, Najma HM, Selvaraj S. Antidiabetic properties of Hibiscus rosa sinensis L. leaf extract fractions on nonobese diabetic (NOD) mouse. Indian J Exp Biol 2011; 49(1): 24-9.
[PMID: 21365992]
[115]
Singh R, Rajasree PH, Sankar C. Screening for anti diabetic activity of the ethanolic extract of Barleria cristata seeds. Int J Pharm Life Sci 2012; 3(10): 2044-7.
[116]
Nain P, Saini V, Sharma S, Nain J. Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats. J Ethnopharmacol 2012; 142(1): 65-71.
[http://dx.doi.org/10.1016/j.jep.2012.04.014] [PMID: 22855943]
[117]
Palanisamy S, Sudha S, Prakash S. Antidiabetic activity of aqueous extract of Padina boergesenii in streptozotocin-induced diabetic rats. Int J Pharma Sci 2014; 6: 418-22.
[118]
Vijayanand S, Wesely EG. Evaluation of antidiabetic activity of Melia azadirach on alloxan induced diabetic rats. Int J Curr Pharm Res 2011; 3: 37-40.
[119]
Ahmad F, Avanapu SR, Shaik RA, Ibrahim M. Phytochemical studies and antioxidant activity of Melia azedarach linn leaves by DPPH scavenging Assay. Int J Pharma Appl 2012; 3(1): 271-6.https://www.researchgate.net/publication/267857371_Phytochemical_studies_and_antioxidant_activity_of_Melia_azedarach_linn_leaves_by_DPPH_scavenging_Assay
[120]
Gorelick J, Rosenberg R, Smotrich A, Hanuš L, Bernstein N. Hypoglycemic activity of withanolides and elicitated Withania somnifera. Phytochemistry 2015; 116: 283-9.
[http://dx.doi.org/10.1016/j.phytochem.2015.02.029] [PMID: 25796090]
[121]
Jena S. Anti-diabetic effects of Withania somnifera root and leaf extracts on streptozotocin induced diabetic rats. J Cell Tissue Res 2018; 13(1): 3597-601.
[122]
Ozougwu J. Anti-diabetic efects of Allium cepa (onions) aqueous extracts on alloxan-induced diabetic Rattus novergicus. Pharmacologyonline 2011; 1: 270-81.
[123]
Rotman-Pikielny P, Ness-Abramof R, Charach G, Roitman A, Zissin R, Levy Y. Efficacy and safety of the dietary supplement DBCare® in patients with type 2 diabetes mellitus and inadequate glycemic control. J Am Coll Nutr 2014; 33(1): 55-62.
[http://dx.doi.org/10.1080/07315724.2014.870008] [PMID: 24533608]
[124]
Senadheera SPA, Ekanayake S, Wanigatunge C. Anti-hyperglycaemic effects of herbal porridge made of Scoparia dulcis leaf extract in diabetics - A randomized crossover clinical trial. BMC Complement Altern Med 2015; 15(1): 410.
[http://dx.doi.org/10.1186/s12906-015-0935-6] [PMID: 26582144]
[125]
Mirfeizi M, Mehdizadeh Tourzani Z, Mirfeizi SZ, Asghari Jafarabadi M, Rezvani HR, Afzali M. Controlling type 2 diabetes mellitus with herbal medicines: A triple-blind randomized clinical trial of efficacy and safety. J Diabetes 2016; 8(5): 647-56.
[http://dx.doi.org/10.1111/1753-0407.12342] [PMID: 26362826]
[126]
Hosseini S, Jamshidi L, Mehrzadi S, et al. Effects of Juglans regia L. leaf extract on hyperglycemia and lipid profiles in type two diabetic patients: A randomized double-blind, placebo-controlled clinical trial. J Ethnopharmacol 2014; 152(3): 451-6.
[http://dx.doi.org/10.1016/j.jep.2014.01.012] [PMID: 24462785]
[127]
Campbell-Tofte JIA, Mølgaard P, Josefsen K, et al. Randomized and double-blinded pilot clinical study of the safety and anti-diabetic efficacy of the Rauvolfia-Citrus tea, as used in Nigerian Traditional Medicine. J Ethnopharmacol 2011; 133(2): 402-11.
[http://dx.doi.org/10.1016/j.jep.2010.10.013] [PMID: 20955771]
[128]
Gul-e-Rana , Karim S,, Khurhsid R, et al. Hypoglycemic activity of Ficus racemosa bark in combination with oral hypoglycemic drug in diabetic human. Acta Pol Pharm 2013; 70(6): 1045-9.
[PMID: 24383328]
[129]
Kianbakht S, Dabaghian FH. Improved glycemic control and lipid profile in hyperlipidemic type 2 diabetic patients consuming Salvia officinalis L. leaf extract: A randomized placebo. Controlled clinical trial. Complement Ther Med 2013; 21(5): 441-6. a
[http://dx.doi.org/10.1016/j.ctim.2013.07.004] [PMID: 24050577]
[130]
Frati Munari AC, Benítez Pinto W, Raúl Ariza Andraca C, Casarrubias M. Lowering glycemic index of food by acarbose and Plantago psyllium mucilage. Arch Med Res 1998; 29(2): 137-41.
[PMID: 9650328]
[131]
Huseini H, Kianbakht S, Hajiaghaee R, Dabaghian F. Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial. Planta Med 2012; 78(4): 311-6.
[http://dx.doi.org/10.1055/s-0031-1280474] [PMID: 22198821]
[132]
Russo EM, Reichelt AA, De-Sá JR, et al. Clinical trial of Myrcia uniflora and Bauhinia forficata leaf extracts in normal and diabetic patients. Braz J Med Biol Res 1990; 23(1): 11-20.
[PMID: 2201413]
[133]
Said O, Fulder S, Khalil K, Azaizeh H, Kassis E, Saad B. Maintaining a physiological blood glucose level with ‘glucolevel’, a combination of four anti-diabetes plants used in the traditional arab herbal medicine. Evid Based Complement Alternat Med 2008; 5(4): 421-8.
[http://dx.doi.org/10.1093/ecam/nem047] [PMID: 18955212]
[134]
Kalita P, Deka S, Saharia BJ, Chakraborty A, Basak M, Deka M. An overview and future scope on traditionally used herbal plants of Assam having antidiabetic activity. Int J Adv Pharm Biol Chem 2014; 3: 299-304.
[135]
Osadebe PO, Odoh EU, Uzor PF. Natural products as potential sources of antidiabetic drugs. J Pharm Res Int 2014; 4: 2075-95.
[136]
Rout SP, Chowdary K, Kar D, Das L. Plants as source of novel anti-diabetic drug: Present scenario and future perspectives. Curr Trends Biotechnol Pharm 2008; 3: 614-32.
[137]
Verma S, Singh S. Current and future status of herbal medicines. Vet World 2008; 1(11): 347.
[http://dx.doi.org/10.5455/vetworld.2008.347-350]
[138]
Kifle ZD, Abdelwuhab M, Melak AD, Genet GM, Meseret T, Adugna M. Pharmacological evaluation of medicinal plants with antidiabetic activities in Ethiopia: A review. Metabolism Open 2022; 13: 100174.
[http://dx.doi.org/10.1016/j.metop.2022.100174] [PMID: 35296054]

Rights & Permissions Print Cite